Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-02-10Clinical Trial Update: A Study to Assess the Efficacy and Safety of Paricalcitol in the Treatment of Chronic Kidney Disease With Secondary Hyperparathyroidism [Phase 3]
Phase 3 clinical trial assessing paricalcitol for secondary hyperparathyroidism in chronic kidney disease; status not specified.
-
CLINICAL_TRIALS trial_result · 2022-02-10Clinical Trial Update: Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With Anemia [Phase 2]
Phase 2 study of Roxadustat in non-dialysis chronic kidney disease patients with anemia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-02-09Clinical Trial Update: Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis [Phase 2]
Phase 2 trial investigating MT-9938 for uremic pruritus in end-stage renal disease patients on hemodialysis was terminated with results post…
-
CLINICAL_TRIALS trial_result · 2022-02-09Clinical Trial Update: The Effect of Enalapril, Losartan or Not Antihypertensive on the Oxidative Status in Renal Transplant Recipients [Phase 2]
Phase 2 trial evaluating the effect of enalapril, losartan, or no antihypertensive therapy on oxidative stress in renal transplant recipient…
-
FDA approval · 2022-02-07FDA Approved: SEVELAMER CARBONATE — Original Application (Micro Labs Limited)
FDA approved the original ANDA for Sevelamer carbonate from Micro Labs Limited, enabling a generic version of the phosphate binder used to t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-02-04Clinical Trial Update: Short-term Use of Dapagliflozin to Protect Kidney Function in CKD Patients [Phase 4]
A Phase 4 clinical trial update evaluating short-term use of dapagliflozin to protect kidney function in chronic renal insufficiency patient…
-
CLINICAL_TRIALS trial_result · 2022-01-31Clinical Trial Update: A Study to Assess the Effect of Verinurad on the Electric Activity of the Heart [Phase 1]
Phase 1 trial assessing the effect of verinurad on heart electrical activity in healthy volunteers, completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-01-27Clinical Trial Update: Optimising Renal Outcome in Myeloma Renal Failure [Phase 2]
Phase 2 trial update on optimizing renal outcome in myeloma-related kidney failure.
-
FDA approval · 2022-01-27FDA Approved: LANTHANUM CARBONATE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's lanthanum carbonate generic product for reducing phosphate levels in patients with end-stage renal disease on dialysis. …
-
CLINICAL_TRIALS trial_result · 2022-01-27Clinical Trial Update: Phase III Clinical Study of Recombinant Erythropoiesis Stimulating Protein Injection (rESP) in the Treatment of Anemia in Hemodialysis Patients With Chronic Renal Failure [Phase 3]
Phase III clinical study investigating recombinant erythropoiesis-stimulating protein (rESP) for anemia in patients with chronic kidney dise…
-
FDA approval · 2022-01-24FDA Approved: DOXERCALCIFEROL — Original Application (Eugia US LLC)
FDA approved an original application for doxercalciferol (generic) by Eugia US LLC.
-
FDA approval · 2022-01-24FDA Approved: LANTHANUM CARBONATE — Original Application (Cipla USA Inc.)
FDA approved Cipla USA Inc.'s generic lanthanum carbonate (original application) for the treatment of hyperphosphatemia in adults with chron…
-
CLINICAL_TRIALS trial_result · 2022-01-14Clinical Trial Update: Renal Actions of Combined Empagliflozin and LINagliptin in Type 2 diabetES [Phase 4]
Phase 4 trial update on the renal effects of combining empagliflozin and linagliptin in type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: CSP594 Comparative Effectiveness in Gout: Allopurinol vs. Febuxostat [Phase 4]
A Phase 4 comparative effectiveness trial comparing allopurinol vs febuxostat in gout patients, including those with chronic kidney disease;…
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: Steroid Free Immunosuppression or Calcineurin Inhibitor Minimization After Basiliximab Induction Therapy in Kidney Transplantation: Comparison With a Standard Quadruple Immunosuppressive Regimen [Phase 4]
Phase 4 clinical trial comparing steroid-free immunosuppression or calcineurin inhibitor minimization after basiliximab induction with a sta…
-
FDA approval · 2022-01-07FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for Sevelamer Carbonate submitted by Bionpharma Inc.
-
CLINICAL_TRIALS withdrawal · 2021-12-09Clinical Trial Update: Association of Diuretics With Change in Extracellular Volume, Natriuretic Peptides, Symptoms, and Cardiovascular Outcomes in CKD [Phase 4]
Phase 4 trial assessing diuretics in chronic kidney disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-12-09Clinical Trial Update: Left Ventricular Hypertrophy and Spironolactone in End Stage Renal Disease [Phase 4]
A Phase 4 trial investigating left ventricular hypertrophy and spironolactone in chronic kidney disease has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2021-12-03Clinical Trial Update: Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D) [Phase 3]
Phase 3 trial update for daprodustat (a novel prolyl hydroxylase inhibitor) in anemia of chronic kidney disease (ASCEND-D) has completed wit…
-
CLINICAL_TRIALS trial_result · 2021-12-01Clinical Trial Update: Use of Patiromer to Transition Chronic Kidney Disease Patients With Hyperkalemia to a Plant-rich Diet. [Phase 4]
Phase 4 clinical trial evaluating patiromer to facilitate transitioning chronic kidney disease patients with hyperkalemia to a plant-rich di…
-
CLINICAL_TRIALS trial_result · 2021-11-24Clinical Trial Update: Desidustat in the Treatment of Anemia in CKD [Phase 3]
Phase 3 trial update for desidustat in treating anemia associated with chronic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2021-11-24Clinical Trial Update: Desidustat in the Treatment of Anemia in CKD on Dialysis Patients [Phase 3]
Phase 3 trial update for desidustat in treating anemia in chronic kidney disease patients on dialysis has completed.
-
CLINICAL_TRIALS trial_result · 2021-11-19Clinical Trial Update: Phase 2 Study of Roxadustat in Participants With Anemia and Chronic Kidney Disease Not Requiring Dialysis [Phase 2]
Phase 2 trial evaluating Roxadustat in anemia associated with chronic kidney disease not requiring dialysis has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2021-11-17Clinical Trial Update: everlinQ endoAVF Post Market Study [NA]
Post-market study update for the everlinQ endoAVF in chronic kidney disease. The study was terminated and results have been posted.
-
CLINICAL_TRIALS trial_result · 2021-11-05Clinical Trial Update: Viekira Pak or Mavyret Treatment for Patient With Chronic Kidney Disease and Hepatitis C [Phase 4]
Phase 4 trial updating outcomes of Viekira Pak or Mavyret in patients with chronic kidney disease and chronic hepatitis C; completed with re…